Quartzy to Expand Digital Lab Supplies Catalog with Bioline, Biotium, MP Biomedicals
Pharmaceutical Technology's In the Lab eNewsletter
Quartzy, an online laboratory supply management company, will offer lab products from Bioline, Biotium, and MP Biomedicals.
On July 24, 2018, Quartzy, an online laboratory supply management and ordering platform, announced three new distributor agreements with Bioline, a wholly owned international company by Meridian Bioscience that develops, manufactures, and markets a range of specialized bioresearch reagents; Biotium, a provider of fluorescence detection technologies and reagents for the life science, pharma, and medical diagnostics industries; and MP Biomedicals, a manufacturer of research products for the life sciences, fine chemicals, and diagnostics industries.
Through this agreement, Quartzy will sell products from Bioline, Biotium, and MP Biomedicals through Quartzy’s shop as well as stock and ship many of these products from Quartzy’s current and future fulfillment centers globally. Product offerings will include specialized reagents, diagnostics, stains, and dyes.
Bioline’s manufacturing portfolio includes more than 300 reagents and kits for molecular biology, cell analysis and nucleic acid, and protein separation and purification. Biotium manufactures and sells more than 3000 R&D products, including reagents for DNA and protein detection, antibody labeling, flow cytometry, polymerase chain reaction, and cell staining. MP Biomedicals manufactures and sells more than 55,000 life science, fine chemical, and diagnostic products globally.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
